Rhinebeck Bancorp, Inc. (RBKB)
NASDAQ: RBKB · Real-Time Price · USD
12.40
-0.29 (-2.29%)
Aug 1, 2025, 4:00 PM - Market closed

Intercept Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1341048610011692
Upgrade
Market Cap Growth
49.90%20.54%-13.17%-14.46%26.83%-24.25%
Upgrade
Last Close Price
12.409.678.059.1110.668.55
Upgrade
PE Ratio
--19.6714.2310.0715.51
Upgrade
PS Ratio
4.314.022.082.152.312.44
Upgrade
PB Ratio
1.040.860.760.920.920.79
Upgrade
P/FCF Ratio
-13.5713.367.2919.817.07
Upgrade
P/OCF Ratio
-12.3012.276.7315.216.18
Upgrade
Debt / Equity Ratio
0.250.731.280.690.250.53
Upgrade
Debt / FCF Ratio
-11.6022.545.445.394.79
Upgrade
Return on Equity (ROE)
-4.65%-7.32%3.96%5.98%9.53%5.23%
Upgrade
Return on Assets (ROA)
-0.45%-0.67%0.33%0.53%0.96%0.56%
Upgrade
Earnings Yield
-4.26%-8.27%5.08%7.03%9.93%6.45%
Upgrade
FCF Yield
-7.37%7.48%13.72%5.05%14.14%
Upgrade
Buyback Yield / Dilution
0.18%0.90%1.35%-0.46%-2.00%-0.30%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.
SEC Filings: 10-K · 10-Q